What are the side effects of Lifitegrast?

Lifitegrast(Lifitegrast) is currently the only prescription drug approved for the treatment of dry eye syndrome. Its main mechanism of action is to target eye inflammation and aim to relieve various uncomfortable symptoms caused by dry eye disease. Dry eye syndrome is a common eye disease that, if left untreated, can cause severe pain, corneal damage, and visual impairment. Therefore, timely and effective treatment of dry eye is crucial.

While undergoing clinical trials, ritasilast demonstrated favorable anti-inflammatory properties and tolerability. However, any drug will be accompanied by certain side effects while exerting its therapeutic effect. It is particularly important for patients taking ritasilast to be aware of possible side effects.

According to clinical study data, common side effects of Ritalast include blurred vision, eye discomfort, eye pain and taste disturbance. These symptoms, although usually not life-threatening, may interfere with the patient's daily life. For example, blurred vision may affect the patient's reading ability or driving safety, while eye discomfort and pain may cause ongoing distress and affect the patient's work and study.

In addition, ritalast may cause some rare and serious allergic reactions. Such reactions include bronchospasm, respiratory distress, pharyngeal edema, tongue swelling, etc. These conditions may be life-threatening and require immediate medical attention. Some patients may experience reactions such as allergic conjunctivitis, dyspnea, angioedema, and atopic dermatitis, and eye swelling and rashes have also been reported.

Although the above-mentioned side effects are not common, patients should remain vigilant while using the drug. To reduce the risk of side effects, patients should provide their doctor with detailed health information before using Litalast, including any history of allergies, other medications they are taking, and any underlying health problems.

Reference materials:https://go.drugbank.com/drugs/DB11611